☆ 4.8 Editorial Material

Natural killer cells and hepatitis C: Natural killer p46 expression linked to antiviral and antifibrotic activity

HEPATOLOGY (2012)

Journal

HEPATOLOGY

Volume 56, Issue 4, Pages 1197-1200

Publisher

WILEY

DOI: 10.1002/hep.25858

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy

Xiaoyue Bi, Si Xie, Shuling Wu, Weihua Cao, Yanjie Lin, Liu Yang, Tingting Jiang, Wen Deng, Shiyu Wang, Ruyu Liu, Yuanjiao Gao, Ge Shen, Min Chang, Hongxiao Hao, Mengjiao Xu, Xiaoxue Chen, Leiping Hu, Yao Lu, Lu Zhang, Yao Xie, Minghui Li

Summary: This study investigated the changes in natural killer (NK) cell phenotype during interferon alpha (IFN-alpha) treatment for chronic hepatitis B (CHB) and its relationship with clinical indicators. The results showed that long-term IFN treatment led to continuous depletion of the killer subpopulation of NK cells and differentiation of the regulatory subpopulation into the killer subpopulation. In the plateau phase, after discontinuation of IFN for a period of time, the number of NK cell subsets gradually recovered but remained lower than that in the initial treatment group.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Immunology

Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients

Akinbami Adenugba, Matthias Hornung, Kilian Weigand, Georg Peschel, Henrik Junger, Paul Kupke, Hauke Lang, Jens U. Marquardt, Tim Zimmermann, Edward K. Geissler, Hans J. Schlitt, Jens M. Werner

Summary: Chronic HCV infection is associated with NK cell activation and decreased IFN gamma production, with altered STAT1 and STAT4 phosphorylation. The addition of RBV to DAA therapy for HCV in LTx recipients enhances pSTAT4-dependent IFN gamma-production in NK cells.

TRANSPLANTATION (2021)

Add to Collection

Review Medicine, Research & Experimental

The antifibrotic role of natural killer cells in liver fibrosis

Yuan Wei, Wang Bingyu, Yang Lei, Yuan Xingxing

Summary: Liver fibrosis is a common pathological change in chronic liver diseases, and this review focuses on the role and potential of NK cells in controlling fibrosis.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Add to Collection

Article Oncology

TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects

Shance Li, Chaoting Zhang, Luyan Shen, Xia Teng, Yefei Xiao, Bentong Yu, Zheming Lu

Summary: NK cells can be engineered for TCR therapy in tumor treatment. A chimeric TCR NK cell was designed and showed antigen-specific recognition and cytotoxicity. This approach has potential clinical applications.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Add to Collection

Article Immunology

Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells

Ratna S. Wijaya, Scott A. Read, Sakthi P. Selvamani, Stephen Schibeci, Mahmoud K. Azardaryany, Adrian Ong, David van der Poorten, Rita Lin, Mark W. Douglas, Jacob George, Golo Ahlenstiel

Summary: Direct acting antiviral therapies clear chronic hepatitis C virus (HCV) infection rapidly and restore natural killer (NK) cell function. Following HCV clearance, NK-cell memory formation involving KLRG1(+) NK cells is observed, which indicates their role in HCV clearance and potential for vaccine design.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors

Ana L. Portillo, Richard Hogg, Sophie M. Poznanski, Eduardo A. Rojas, Niamh J. Cashell, Joanne A. Hammill, Marianne Chew, Mira M. Shenouda, Tyrah M. Ritchie, Quynh T. Cao, Jeremy A. Hirota, Sukhbinder Dhesy-Thind, Jonathan L. Bramson, Ali A. Ashkar

Summary: The study shows that HER2 CAR-NK cells enhance anti-tumor functions against HER2-expressing cancer cells without affecting non-malignant cells, suggesting a promising and safe immunotherapy option for solid tumors.

ISCIENCE (2021)

Add to Collection

Article Oncology

TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus-related hepatocellular carcinoma

Lihua Yu, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Yuyong Jiang, Juan Du, Zhiyun Yang

Summary: Research has found that the co-expression of TIGIT and TIM-3 on NK cells is elevated in patients with HBV-HCC, leading to functional dysfunction that may be closely related to disease progression.

ONCOIMMUNOLOGY (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D

Madeline J. Lee, Michelle W. Leong, Arjun Rustagi, Aimee Beck, Leiping Zeng, Susan Holmes, Lei S. Qi, Catherine A. Blish

Summary: SARS-CoV-2 evades direct killing by natural killer (NK) cells by downregulating ligands for the activating receptor NKG2D. The viral protein Nsp1 mediates the downregulation of NKG2D ligands and alone is sufficient to confer resistance to NK cell killing.

CELL REPORTS (2022)

Add to Collection

Article Oncology

Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients

Takeji Umemura, Satoru Joshita, Hiromi Saito, Shun-ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Tomoo Yamazaki, Masao Ota

Summary: Natural killer cells, mediated through KIR-HLA interactions, play a role in hepatocellular carcinoma (HCC) development. In patients with hepatitis C virus-associated cirrhosis, the presence of HLA-Bw4 and the KIR3DL1 + HLA-Bw4 pair was significantly associated with HCC onset, suggesting a potential risk factor for HCC development in HCV cirrhosis.

CANCERS (2021)

Add to Collection

Article Chemistry, Medicinal

In Vitro Antiviral Activity of Tyrosinase from Mushroom Agaricus bisporus against Hepatitis C Virus

David Lopez-Tejedor, Rafael Claveria-Gimeno, Adrian Velazquez-Campoy, Olga Abian, Jose M. Palomo

Summary: Tyrosinases extracted and purified from commercial Agaricus bisporus protein extract and white mushrooms demonstrated high antiviral activity against hepatitis C virus. The newly discovered 50 kDa isoform showed even greater antiviral capacity than the well-known 45 kDa isoform. This antiviral activity was directly related to the enzymatic activity of tyrosinases.

PHARMACEUTICALS (2021)

Add to Collection

Article Medicine, General & Internal

Relationship between Serum Cortisol, Dehydroepiandrosterone Sulfate (DHEAS) Levels, and Natural Killer Cell Activity: A Cross-Sectional Study

Eunkyung Suh, A-Ra Cho, Ji-Hee Haam, Minchan Gil, Yun-Kyong Lee, Young-Sang Kim

Summary: This study investigated the relationship between cortisol and DHEAS serum concentrations, their ratio (CDR), and natural killer cell activity (NKA). The results showed that high levels of cortisol and CDR were associated with low NKA, while high levels of DHEAS were associated with high NKA in premenopausal women.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Immunology

Novaferon gene modification promotes NK92 cell anti-tumor activity

Wanze Zhang, Bingxin Yu, Qingyu Meng, Luya Pu, Bin Liu, Fan Li

Summary: The novel IFN-like protein Novaferon, generated through gene shuffling, enhances the antitumor activity of NK cells by increasing the secretion of cytokines and upregulating activating receptors. In experiments, NK92-nova cells demonstrated stronger antitumor activity, inhibiting the growth of HepG2 cells without causing systemic toxicity.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Add to Collection

Review Cell Biology

Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis

Anshika Jangra, Ashish Kothari, Phulen Sarma, Bikash Medhi, Balram Ji Omar, Karanvir Kaushal

Summary: This review provides an overview of recent antifibrotic treatment modalities for the treatment of liver cirrhosis, as well as a brief summary of clinical trials conducted to date.

CELLS (2022)

Add to Collection

Article Immunology

The X-linked epigenetic regulator UTX controls NK cell-intrinsic sex differences

Mandy I. Cheng, Joey H. Li, Luke Riggan, Bryan Chen, Rana Yakhshi Tafti, Scott Chin, Feiyang Ma, Matteo Pellegrini, Haley Hrncir, Arthur P. Arnold, Timothy E. O'Sullivan, Maureen A. Su

Summary: The outcomes of viral infections are influenced by sex, with males being more susceptible. Surprisingly, males have increased numbers of antiviral natural killer (NK) cells. However, these NK cells in males display decreased effector function compared to females in both mice and humans. The differences are not solely dependent on gonadal hormones and are associated with lower levels of UTX, an epigenetic regulator, in male NK cells. On the other hand, NK cell-intrinsic UTX deficiency in female mice increases NK cell numbers and reduces effector responses, leading to increased lethality to mouse cytomegalovirus.

NATURE IMMUNOLOGY (2023)

Add to Collection

Review Cell Biology

Hepatitis E Virus Infection-Immune Responses to an Underestimated Global Threat

Paul Kupke, Jens M. Werner

Summary: Hepatitis E virus infection is a major cause of acute hepatitis development, especially in immunocompromised patients. Current treatment options for HEV are limited, and research on the immune mechanisms involved in HEV infection is still lacking.

CELLS (2021)

Add to Collection

Article Rheumatology

Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists

Ales Janda, Catharina Schuetz, Scott Canna, Mark Gorelik, Maximilian Heeg, Kirsten Minden, Claas Hinze, Ansgar Schulz, Klaus-Michael Debatin, Christian M. Hedrich, Fabian Speth

Summary: Data on therapy of COVID-19 in immunocompetent and immunosuppressed children are limited. Pediatric rheumatologists tend to use off-label therapies and recommend specific medications based on the stage of COVID-19 in patients. In children with autoimmune/inflammatory diseases, most respondents do not support preventive adaptation of immunomodulating therapy.

RHEUMATOLOGY INTERNATIONAL (2021)

Add to Collection

Letter Allergy

International multicenter experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency

Anna-Maria Globig, Maximilian Heeg, Carsten Schade Larsen, Ruben Duarte Ferreira, Gerhard Kindle, Sigune Goldacker, Valentina Strohmeier, Susana L. Silva, Charlotte Cunningham-Rundles, Isabella Quinti, Robert Thimme, Dominik Bettinger, Michael Schultheiss, Klaus Warnatz

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Exhaustion of CD39-Expressing CD8+ T Cells in Crohn's Disease Is Linked to Clinical Outcome

Anna-Maria Globig, Lena Sophie Mayer, Maximilian Heeg, Geoffroy Andrieux, Manching Ku, Patricia Otto-Mora, Anna Veronika Hipp, Katharina Zoldan, Ajinkya Pattekar, Nisha Rana, Christoph Schell, Melanie Boerries, Maike Hofmann, Christoph Neumann-Haefelin, Armin Kuellmer, Arthur Schmidt, Tobias Boettler, Vesselin Tomov, Robert Thimme, Peter Hasselblatt, Bertram Bengsch

Summary: This study identified the role of exhaustion of peripheral CD39-expressing CD8 T cell subsets in Crohn's disease. The low frequency of these subsets highlighted the usefulness of single-cell cytometry methods for identifying relevant immune populations. The exhaustion status of these subsets was linked to the clinical activity, and their specific gene signatures have implications for exhaustion-based personalized medicine approaches.

GASTROENTEROLOGY (2022)

Add to Collection

Article Allergy

STAT3-confusion-of-function: Beyond the loss and gain dualism

Lorenzo Lodi, Laura Eva Faletti, Maria Elena Maccari, Filippo Consonni, Miriam Gross, Ilaria Pagnini, Silvia Ricci, Maximilian Heeg, Gabriele Simonini, Chiara Azzari, Stephan Ehl

Summary: This study describes a patient with Sjogren syndrome and features of AD-HIES caused by a germline R335W-STAT3 variant. The study provides insights into the clinical and immunological phenotype, as well as the molecular consequences of this variant. The findings suggest that the R335W-STAT3 variant displays both gain-of-function and loss-of-function features, challenging the traditional dualism of gain-versus loss-of-function.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency

Anna-Maria Globig, Valentina Strohmeier, Rambabu Surabattula, Diana J. Leeming, Morten A. Karsdal, Maximilian Heeg, Gerhard Kindle, Sigune Goldacker, Caroline von Spee-Mayer, Michele Proietti, Birke Bausch, Dominik Bettinger, Michael Schultheiss, Robert Thimme, Detlef Schuppan, Klaus Warnatz

Summary: Portal hypertension, a manifestation in some CVID patients, is usually not associated with liver cirrhosis. Spleen enlargement and elevated liver stiffness have been identified as markers for further evaluation of portal hypertension in CVID, but better liquid biomarkers are needed for diagnosing this serious complication.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Tissue-resident memory CD8(+) T cells possess unique transcriptional, epigenetic and functional adaptations to different tissue environments

John T. Crowl, Maximilian Heeg, Amir Ferry, J. Justin Milner, Kyla D. Omilusik, Clara Toma, Zhaoren He, John T. Chang, Ananda W. Goldrath

Summary: This study investigates the diversity of gene expression and genome accessibility in mouse CD8(+) T-RM cells in different tissues, and identifies molecules critical for the generation of CD8(+) T-RM cells in response to acute viral infection. The research reveals both common and tissue-specific transcriptional and epigenetic signatures in T-RM cells from different organs. T-RM cells in the intestine and salivary glands express TGF-beta-induced genes and are maintained by ongoing TGF-beta signaling, while those in the fat, kidney, and liver do not. Furthermore, the study identifies the transcriptional repressor Hic1 as a critical regulator of T-RM cell differentiation in the small intestine, and shows that Hic1 overexpression enhances T-RM cell differentiation and protection from infection.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signature

A-M Globig, A. Hipp, P. Otto-Mora, M. Heeg, L. S. Mayer, S. Ehl, H. Schwacha, M. Bewtra, V Tomov, R. Thimme, P. Hasselblatt, B. Bengsch

Summary: The T cell compartment in patients with Crohn's disease is dysregulated, and an enrichment of Tc17 cells during active disease suggests CD6 as a potential therapeutic target. The identified Tc17 signature may guide personalized treatment decisions in Crohn's disease.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Allergy

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

Jennifer W. Leiding, Tiphanie P. Vogel, Valentine G. J. Santarlas, Rahul Mhaskar, Madison R. Smith, Alexandre Carisey, Alexander Vargas-Hernandez, Manuel Silva-Carmona, Maximilian Heeg, Anne Rensing-Ehl, Benedicte Neven, Jerome Hadjadj, Sophie Hambleton, Timothy Ronan Leahy, Kornvalee Meesilpavikai, Charlotte Cunningham-Rundles, Cullen M. Dutmer, Svetlana O. Sharapova, Mervi Taskinen, Ignatius Chua, Rosie Hague, Christian Klemann, Larysa Kostyuchenko, Tomohiro Morio, Akaluck Thatayatikom, Ahmet Ozen, Anna Scherbina, Cindy S. Bauer, Sarah E. Flanagan, Eleonora Gambineri, Lisa Giovannini-Chami, Jennifer Heimall, Kathleen E. Sullivan, Eric Allenspach, Nei Romberg, Sean G. Deane, Benjamin T. Prince, Melissa J. Rose, John Bohnsack, Talal Mousallem, Rohith Jesudas, Maria Marluce Dos Santos Vilela, Michael O'Sullivan, Jana Pachlopnik Schmid, Stepanka Pruhova, Adam Klocperk, Matthew Rees, Helen Su, Sami Bahna, Saf Baris, Lisa M. Bartnikas, Amy Chang Berger, Tracy A. Briggs, Shannon Brothers, Vanessa Bundy, Alice Y. Chan, Shanmuganathan Chandrakasan, Mette Christiansen, Theresa Cole, Matthew C. Cook, Mukesh M. Desai, Ute Fischer, David A. Fulcher, Silvanna Gallo, Amelie Gauthier, Andrew R. Gennery, Jose Goncalo Marques, Frederic Gottrand, Bodo Grimbacher, Eyal Grunebaum, Emma Haapaniemi, Sari Hamalainen, Kaarina Heiskanen, Tarja Heiskanen-Kosma, Hal M. Hoffman, Luis Ignacio Gonzalez-Granado, Anthony L. Guerrerio, Leena Kainulainen, Ashish Kumar, Monica G. Lawrence, Carina Levin, Timi Martelius, Olaf Neth, Peter Olbrich, Alejandro Palma, Niraj C. Patel, Tamara Pozos, Kahn Preece, Saul Oswaldo Lugo Reyes, Mark A. Russell, Yael Schejter, Christine Seroogy, Jan Sinclair, Effie Skevofilax, Daniel Suan, Daniel Suez, Paul Szabolcs, Helena Velasco, Klaus Warnatz, Kelly Walkovich, Austen Worth, Mikko R. J. Seppanen, Troy R. Torgerson, Georgios Sogkas, Stephan Ehl, Stuart G. Tangye, Megan A. Cooper, Joshua D. Milner, Lisa R. Forbes Satter

Summary: This pivotal cohort study defines the scope, natural history, treatment, and overall survival of a large global cohort of patients with pathogenic STAT3 GOF variants. The study found that patients with this variant present with a wide array of immune-mediated disease including lymphoproliferation, autoimmune cytopenias, and multisystem autoimmunity. Early identification and prompt treatment implementation are crucial for the survival of these patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Allergy

Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations

Maria Elena Maccari, Pascal Schneider, Cristian Roberto Smulski, Andrea Meinhardt, Fernando Pinto, Luis Ignacio Gonzalez-Granado, Catharina Schuetz, Mauricio Pablo Sica, Miriam Gross, Ilka Fuchs, Patrick Kury, Maximilian Heeg, Tatjana Vocat, Laure Willen, Caroline Thomas, Regina Huehn, Aude Magerus, Myriam Lorenz, Klaus Schwarz, Frederic Rieux-Laucat, Stephan Ehl, Anne Rensing-Ehl

Summary: Heterozygous loss-of-function mutations in FASLG are better tolerated than in FAS, and usually do not result in expanded double-negative T cells (DNT) and elevated serum vitamin B12 levels, which are characteristic of autoimmune-lymphoproliferative syndrome (ALPS).

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection

Eva-Maria Jacobsen, Dorit Fabricius, Magdalena Class, Fernando Topfstedt, Raquel Lorenzetti, Iga Janowska, Franziska Schmidt, Julian Staniek, Maria Zernickel, Thomas Stamminger, Andrea N. Dietz, Angela Zellmer, Manuel Hecht, Peter Rauch, Carmen Blum, Carolin Ludwig, Bernd Jahrsdoerfer, Hubert Schrezenmeier, Maximilian Heeg, Benjamin Mayer, Alina Seidel, Ruediger Gross, Jan Muench, Frank Kirchhoff, Sebastian F. N. Bode, Gudrun Strauss, Hanna Renk, Roland Elling, Maximillian Stich, Reinhard E. Voll, Burkhard Toenshof, Axel R. Franz, Philipp Henneke, Klaus-Michael Debatin, Marta Rizzi, Ales Janda

Summary: The severity and immune response of SARS-CoV-2 infection differ in adults and children. Children show a plasmablast-driven initial response, enhanced specific antibody response, and lower but detectable specific B and T cell responses compared to their parents. After one year, children exhibit an increase in S1-specific IgA class switch and enhanced T cell maturation.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Immunology

DNA architectural protein CTCF facilitates subset-specific chromatin interactions to limit the formation of memory CD8+T cells

Sara Quon, Bingfei Yu, Brendan E. Russ, Kirill Tsyganov, Hongtuyet Nguyen, Clara Toma, Maximilian Heeg, James D. Hocker, J. Justin Milner, Shane Crotty, Matthew E. Pipkin, Stephen J. Turner, Ananda W. Goldrath

Summary: Using the Hi-C technique, we investigated the relationship between genome configuration and CD8+ T cell differentiation. We found that CTCF mutations can affect the expression of terminal-effector genes, indicating that CTCF not only participates in genome organization, but also regulates the diversity of effector CD8+ T cells by altering interactions that regulate the transcription factor landscape and transcriptome.

IMMUNITY (2023)

Add to Collection

Review Immunology

Insights into phenotypic and functional CD8+ TRM heterogeneity

Maximilian Heeg, Ananda W. Goldrath

Summary: Cytotoxic CD8(+) T cells recognize and eliminate infected or cancerous cells. Tissue-resident memory T cells (T-RM) reside in peripheral tissues and are able to acclimate to the tissue environment for long-term survival.

IMMUNOLOGICAL REVIEWS (2023)

Add to Collection

Article Immunology

JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences

Nils Ott, Laura Faletti, Maximilian Heeg, Virginia Andreani, Bodo Grimbacher

Summary: The JAK/STAT signaling pathway is involved in various cellular processes and can be disrupted by mutations. It offers potential for personalized medicine and has implications for immunological diseases. Mutations in STAT1, STAT3, STAT6, JAK1, and JAK3 result in distinct clinical phenotypes.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Add to Collection

Editorial Material Immunology

License to kill: Retinoic acid programs T cells for tissue residency

Maximilian Heeg, Ananda W. Goldrath

Summary: In this JEM paper, Qiu et al. (2023) demonstrate that retinoic acid signaling in the mesenteric lymph node promotes the development of CD8(+) T cells into small intestinal tissue-resident memory cells. This finding sheds light on tissue-specific vaccination strategies.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Add to Collection

Article Immunology

Transcriptional programming of CD4+TRM differentiation in viral infection balances effector- and memory-associated gene expression

Quynh P. Nguyen, Kennidy K. Takehara, Tianda Z. Deng, Shannon O'Shea, Maximilian Heeg, Kyla D. Omilusik, J. Justin Milner, Sara Quon, Matthew E. Pipkin, Jinyong Choi, Shane Crotty, Ananda W. Goldrath

Summary: After infection, T cells differentiate into long-lived memory cells that can circulate through secondary lymphoid organs or reside in tissues. CD4+ tissue-resident memory T cells (TRM) in the small intestine (SI) responding to acute viral infection share a gene expression program and chromatin accessibility profile with circulating TH1 cells, and gradually acquire a mature TRM program. Single-cell RNA sequencing reveals heterogeneity among established CD4+ TRM, predominantly located in the lamina propria, and identifies a population of cells that coexpress both effector- and memory-associated genes. Transcriptional regulators Blimp1, Id2, and Bcl6 are required for the formation and development of CD4+ TRM in the SI. These findings provide insights into the development, differentiation, and persistence of CD4+ TRM in response to viral infection.

SCIENCE IMMUNOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.